NR566 ADVANCED PHARMACOLOGY
COMPREHENSIVE EXAM (LATEST 2026/
2027 UPDATE) QUESTIONS AND 100%
CORRECT VERIFIED ANSWERS| GRADE
A+
1. A 64-year-old male with a history of chronic kidney disease (CKD) Stage 3b is diagnosed
with a severe skin infection. Which antibiotic requires significant dosage adjustment due to
its primary renal excretion and narrow therapeutic index?
A. Vancomycin
B. Ceftriaxone
C. Azithromycin
D. Clindamycin
Answer: A
Conceptual Explanation: Vancomycin is primarily excreted by the kidneys and requires
dose adjustments based on creatinine clearance and trough levels to prevent
nephrotoxicity and ototoxicity.
2. When prescribing an ACE inhibitor to a patient with diabetes and hypertension, the nurse
practitioner must monitor for which specific electrolyte imbalance?
A. Hypokalemia
,B. Hyperkalemia
C. Hypermagnesemia
D. Hyponatremia
Answer: B
Conceptual Explanation: ACE inhibitors block the conversion of Angiotensin I to
Angiotensin II, leading to decreased aldosterone secretion, which results in potassium
retention.
3. Which of the following describes the mechanism of action of a competitive antagonist?
A. It binds to the same site as the agonist but does not activate it.
B. It binds to the receptor and produces a sub-maximal response.
C. It binds to an allosteric site to change receptor shape.
D. It permanently inactivates the receptor via covalent bonding.
Answer: A
Conceptual Explanation: Competitive antagonists compete with agonists for the same
binding site on a receptor without activating the receptor, shifting the dose-response curve
to the right.
4. A patient is taking Warfarin for atrial fibrillation. They are started on Amiodarone for
rhythm control. What should the NP expect to do with the Warfarin dose?
A. Increase the dose of Warfarin.
, B. Keep the dose the same and monitor INR monthly.
C. Discontinue Warfarin and start Aspirin.
D. Decrease the dose of Warfarin by 30-50%.
Answer: D
Conceptual Explanation: Amiodarone inhibits CYP2C9, the enzyme responsible for
metabolizing S-warfarin, leading to increased INR and bleeding risk; a proactive dose
reduction is necessary.
5. Which medication is considered first-line for a patient with Type 2 Diabetes and
established Atherosclerotic Cardiovascular Disease (ASCVD)?
A. Empagliflozin
B. Pioglitazone
C. Glipizide
D. Sitagliptin
Answer: A
Conceptual Explanation: SGLT2 inhibitors like Empagliflozin and GLP-1 RAs have proven
cardiovascular benefits and are recommended first-line for patients with ASCVD according
to ADA guidelines.
COMPREHENSIVE EXAM (LATEST 2026/
2027 UPDATE) QUESTIONS AND 100%
CORRECT VERIFIED ANSWERS| GRADE
A+
1. A 64-year-old male with a history of chronic kidney disease (CKD) Stage 3b is diagnosed
with a severe skin infection. Which antibiotic requires significant dosage adjustment due to
its primary renal excretion and narrow therapeutic index?
A. Vancomycin
B. Ceftriaxone
C. Azithromycin
D. Clindamycin
Answer: A
Conceptual Explanation: Vancomycin is primarily excreted by the kidneys and requires
dose adjustments based on creatinine clearance and trough levels to prevent
nephrotoxicity and ototoxicity.
2. When prescribing an ACE inhibitor to a patient with diabetes and hypertension, the nurse
practitioner must monitor for which specific electrolyte imbalance?
A. Hypokalemia
,B. Hyperkalemia
C. Hypermagnesemia
D. Hyponatremia
Answer: B
Conceptual Explanation: ACE inhibitors block the conversion of Angiotensin I to
Angiotensin II, leading to decreased aldosterone secretion, which results in potassium
retention.
3. Which of the following describes the mechanism of action of a competitive antagonist?
A. It binds to the same site as the agonist but does not activate it.
B. It binds to the receptor and produces a sub-maximal response.
C. It binds to an allosteric site to change receptor shape.
D. It permanently inactivates the receptor via covalent bonding.
Answer: A
Conceptual Explanation: Competitive antagonists compete with agonists for the same
binding site on a receptor without activating the receptor, shifting the dose-response curve
to the right.
4. A patient is taking Warfarin for atrial fibrillation. They are started on Amiodarone for
rhythm control. What should the NP expect to do with the Warfarin dose?
A. Increase the dose of Warfarin.
, B. Keep the dose the same and monitor INR monthly.
C. Discontinue Warfarin and start Aspirin.
D. Decrease the dose of Warfarin by 30-50%.
Answer: D
Conceptual Explanation: Amiodarone inhibits CYP2C9, the enzyme responsible for
metabolizing S-warfarin, leading to increased INR and bleeding risk; a proactive dose
reduction is necessary.
5. Which medication is considered first-line for a patient with Type 2 Diabetes and
established Atherosclerotic Cardiovascular Disease (ASCVD)?
A. Empagliflozin
B. Pioglitazone
C. Glipizide
D. Sitagliptin
Answer: A
Conceptual Explanation: SGLT2 inhibitors like Empagliflozin and GLP-1 RAs have proven
cardiovascular benefits and are recommended first-line for patients with ASCVD according
to ADA guidelines.
